StockData
QIAGEN N.V. logo

QIAGEN N.V. (QGEN) stock

QGENNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 10/30
$49.75−0.06 (-0.12%)

Close on Nov 17, 2026Market cap $10.79BP/E 25.6Yield 0.50%

Qiagen enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Qiagen's enterprise value was $11.57B on Nov 11, 2026, against $11.53B a year earlier. Over the last 5 years it ranged from $8.12B to $14.91B, with a median of $11.29B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$11.57B+6.3%
2025Dec 31, 2025$10.88B+1.4%
2024Dec 31, 2024$10.72B-2.2%
2023Dec 29, 2023$10.97B-16.0%
2022Dec 30, 2022$13.06B-12.4%
2021Dec 31, 2021$14.91B+9.9%
2020Dec 31, 2020$13.56B+49.3%
2019Dec 31, 2019$9.09B-1.1%
2018Dec 31, 2018$9.19B+10.5%
2017Dec 29, 2017$8.32B+8.5%
2016Dec 30, 2016$7.67B-0.0%
2015Dec 31, 2015$7.67B+18.9%
2014Dec 31, 2014$6.45B+2.5%
2013Dec 31, 2013$6.30B+31.2%
2012Dec 31, 2012$4.80B–
2011Dec 30, 2011-$58.09M-101.2%
2010Dec 31, 2010$4.83B+8.1%
2009Dec 31, 2009$4.47B–

More Qiagen figures

See a number that looks wrong?